ライフサイエンスにおけるジェネレーティブAIの世界市場 2025-2029

ライフサイエンスにおけるジェネレーティブAI市場は2024-2029年に10億5,580万米ドル、予測期間中のCAGRは20.3%で成長すると予測されます。

当レポートでは、ライフサイエンスにおけるジェネレーティブAI市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、研究開発の効率化、大量かつマルチモーダルな生物学的データの普及、基盤となるAIおよびコンピューティングインフラストラクチャの進歩によって牽引されています。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。レポートには、主要企業の分析に加え、包括的な市場規模データ、地域別分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、今後数年間のライフサイエンスにおけるジェネレーティブAI市場の成長を促進する主な要因の1つとして、統合型クローズドループ探索プラットフォームの出現を挙げています。また、生物学のための大規模な基盤モデルの開発や、探索から臨床および規制用途への拡大が、市場の大きな需要につながります。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 Technavio分析

• 価格・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
• インプットの重要性と差別化の要因
• 混乱の要因
• 促進要因と課題の影響

第3章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第4章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 2024
• 市場の見通し 2024-2029

第5章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第6章 市場セグメンテーション：用途別

• 市場セグメント
• 比較：用途別
• 創薬：市場規模と予測 2024-2029
• パーソナライズ医療：市場規模と予測 2024-2029
• 臨床試験：市場規模と予測 2024-2029
• 市場機会：用途別

第7章 市場セグメンテーション：技術別

• 市場セグメント
• 比較：技術別
• 新しい分子生成：市場規模と予測 2024-2029
• タンパク質配列設計：市場規模と予測 2024-2029
• 合成遺伝子設計：市場規模と予測 2024-2029
• 市場機会：技術別

第8章 市場セグメンテーション：展開別

• 市場セグメント
• 比較：展開別
• クラウドベース：市場規模と予測 2024-2029
• オンプレミス：市場規模と予測 2024-2029
• ハイブリッド：市場規模と予測 2024-2029
• 市場機会：展開別

第9章 顧客情勢

• 顧客情勢の概要

第10章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 2024-2029
• 欧州：市場規模と予測 2024-2029
• アジア太平洋：市場規模と予測 2024-2029
• 中東・アフリカ：市場規模と予測 2024-2029
• 南米：市場規模と予測 2024-2029
• 米国：市場規模と予測 2024-2029
• カナダ：市場規模と予測 2024-2029
• 中国：市場規模と予測 2024-2029
• ドイツ：市場規模と予測 2024-2029
• 英国：市場規模と予測 2024-2029
• メキシコ：市場規模と予測 2024-2029
• フランス：市場規模と予測 2024-2029
• 日本：市場規模と予測 2024-2029
• インド：市場規模と予測 2024-2029
• オランダ：市場規模と予測 2024-2029
• 市場機会：地域情勢別

第11章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第12章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第13章 競合分析

• 企業プロファイル
• 企業ランキング指数
• 企業の市場ポジショニング
• AiCure
• Atomwise Inc.
• BenevolentAI
• Boehringer Ingelheim International GmbH
• Google LLC
• Insilico Medicine
• International Business Machines Corp.
• Microsoft Corp.
• NVIDIA Corp.
• Owkin Inc.
• PathAI Inc.
• Recursion Pharmaceuticals Inc.
• Sanofi SA
• Schrodinger Inc.
• SOPHiA GENETICS

第14章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Application
• Exhibits6: Executive Summary - Chart on Market Segmentation by Technology
• Exhibits7: Executive Summary - Chart on Market Segmentation by Deployment
• Exhibits8: Executive Summary - Chart on Incremental Growth
• Exhibits9: Executive Summary - Data Table on Incremental Growth
• Exhibits10: Executive Summary - Chart on Company Market Positioning
• Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits12: Overview on criticality of inputs and factors of differentiation
• Exhibits13: Overview on factors of disruption
• Exhibits14: Impact of drivers and challenges in 2024 and 2029
• Exhibits15: Parent Market
• Exhibits16: Data Table on - Parent Market
• Exhibits17: Market characteristics analysis
• Exhibits18: Value chain analysis
• Exhibits19: Offerings of companies included in the market definition
• Exhibits20: Market segments
• Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
• Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
• Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
• Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
• Exhibits25: Five forces analysis - Comparison between 2024 and 2029
• Exhibits26: Bargaining power of buyers - Impact of key factors 2024 and 2029
• Exhibits27: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• Exhibits28: Threat of new entrants - Impact of key factors in 2024 and 2029
• Exhibits29: Threat of substitutes - Impact of key factors in 2024 and 2029
• Exhibits30: Threat of rivalry - Impact of key factors in 2024 and 2029
• Exhibits31: Chart on Market condition - Five forces 2024 and 2029
• Exhibits32: Chart on Application - Market share 2024-2029 (%)
• Exhibits33: Data Table on Application - Market share 2024-2029 (%)
• Exhibits34: Chart on Comparison by Application
• Exhibits35: Data Table on Comparison by Application
• Exhibits36: Chart on Drug discovery - Market size and forecast 2024-2029 ($ million)
• Exhibits37: Data Table on Drug discovery - Market size and forecast 2024-2029 ($ million)
• Exhibits38: Chart on Drug discovery - Year-over-year growth 2024-2029 (%)
• Exhibits39: Data Table on Drug discovery - Year-over-year growth 2024-2029 (%)
• Exhibits40: Chart on Personalized medicine - Market size and forecast 2024-2029 ($ million)
• Exhibits41: Data Table on Personalized medicine - Market size and forecast 2024-2029 ($ million)
• Exhibits42: Chart on Personalized medicine - Year-over-year growth 2024-2029 (%)
• Exhibits43: Data Table on Personalized medicine - Year-over-year growth 2024-2029 (%)
• Exhibits44: Chart on Clinical trials - Market size and forecast 2024-2029 ($ million)
• Exhibits45: Data Table on Clinical trials - Market size and forecast 2024-2029 ($ million)
• Exhibits46: Chart on Clinical trials - Year-over-year growth 2024-2029 (%)
• Exhibits47: Data Table on Clinical trials - Year-over-year growth 2024-2029 (%)
• Exhibits48: Market opportunity by Application ($ million)
• Exhibits49: Data Table on Market opportunity by Application ($ million)
• Exhibits50: Chart on Technology - Market share 2024-2029 (%)
• Exhibits51: Data Table on Technology - Market share 2024-2029 (%)
• Exhibits52: Chart on Comparison by Technology
• Exhibits53: Data Table on Comparison by Technology
• Exhibits54: Chart on Novel molecule generation - Market size and forecast 2024-2029 ($ million)
• Exhibits55: Data Table on Novel molecule generation - Market size and forecast 2024-2029 ($ million)
• Exhibits56: Chart on Novel molecule generation - Year-over-year growth 2024-2029 (%)
• Exhibits57: Data Table on Novel molecule generation - Year-over-year growth 2024-2029 (%)
• Exhibits58: Chart on Protein sequence design - Market size and forecast 2024-2029 ($ million)
• Exhibits59: Data Table on Protein sequence design - Market size and forecast 2024-2029 ($ million)
• Exhibits60: Chart on Protein sequence design - Year-over-year growth 2024-2029 (%)
• Exhibits61: Data Table on Protein sequence design - Year-over-year growth 2024-2029 (%)
• Exhibits62: Chart on Synthetic gene design - Market size and forecast 2024-2029 ($ million)
• Exhibits63: Data Table on Synthetic gene design - Market size and forecast 2024-2029 ($ million)
• Exhibits64: Chart on Synthetic gene design - Year-over-year growth 2024-2029 (%)
• Exhibits65: Data Table on Synthetic gene design - Year-over-year growth 2024-2029 (%)
• Exhibits66: Market opportunity by Technology ($ million)
• Exhibits67: Data Table on Market opportunity by Technology ($ million)
• Exhibits68: Chart on Deployment - Market share 2024-2029 (%)
• Exhibits69: Data Table on Deployment - Market share 2024-2029 (%)
• Exhibits70: Chart on Comparison by Deployment
• Exhibits71: Data Table on Comparison by Deployment
• Exhibits72: Chart on Cloud-based - Market size and forecast 2024-2029 ($ million)
• Exhibits73: Data Table on Cloud-based - Market size and forecast 2024-2029 ($ million)
• Exhibits74: Chart on Cloud-based - Year-over-year growth 2024-2029 (%)
• Exhibits75: Data Table on Cloud-based - Year-over-year growth 2024-2029 (%)
• Exhibits76: Chart on On-premises - Market size and forecast 2024-2029 ($ million)
• Exhibits77: Data Table on On-premises - Market size and forecast 2024-2029 ($ million)
• Exhibits78: Chart on On-premises - Year-over-year growth 2024-2029 (%)
• Exhibits79: Data Table on On-premises - Year-over-year growth 2024-2029 (%)
• Exhibits80: Chart on Hybrid - Market size and forecast 2024-2029 ($ million)
• Exhibits81: Data Table on Hybrid - Market size and forecast 2024-2029 ($ million)
• Exhibits82: Chart on Hybrid - Year-over-year growth 2024-2029 (%)
• Exhibits83: Data Table on Hybrid - Year-over-year growth 2024-2029 (%)
• Exhibits84: Market opportunity by Deployment ($ million)
• Exhibits85: Data Table on Market opportunity by Deployment ($ million)
• Exhibits86: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits87: Chart on Market share By Geographical Landscape 2024-2029 (%)
• Exhibits88: Data Table on Market share By Geographical Landscape 2024-2029 (%)
• Exhibits89: Chart on Geographic comparison
• Exhibits90: Data Table on Geographic comparison
• Exhibits91: Chart on North America - Market size and forecast 2024-2029 ($ million)
• Exhibits92: Data Table on North America - Market size and forecast 2024-2029 ($ million)
• Exhibits93: Chart on North America - Year-over-year growth 2024-2029 (%)
• Exhibits94: Data Table on North America - Year-over-year growth 2024-2029 (%)
• Exhibits95: Chart on Europe - Market size and forecast 2024-2029 ($ million)
• Exhibits96: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
• Exhibits97: Chart on Europe - Year-over-year growth 2024-2029 (%)
• Exhibits98: Data Table on Europe - Year-over-year growth 2024-2029 (%)
• Exhibits99: Chart on APAC - Market size and forecast 2024-2029 ($ million)
• Exhibits100: Data Table on APAC - Market size and forecast 2024-2029 ($ million)
• Exhibits101: Chart on APAC - Year-over-year growth 2024-2029 (%)
• Exhibits102: Data Table on APAC - Year-over-year growth 2024-2029 (%)
• Exhibits103: Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
• Exhibits104: Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
• Exhibits105: Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
• Exhibits106: Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
• Exhibits107: Chart on South America - Market size and forecast 2024-2029 ($ million)
• Exhibits108: Data Table on South America - Market size and forecast 2024-2029 ($ million)
• Exhibits109: Chart on South America - Year-over-year growth 2024-2029 (%)
• Exhibits110: Data Table on South America - Year-over-year growth 2024-2029 (%)
• Exhibits111: Chart on US - Market size and forecast 2024-2029 ($ million)
• Exhibits112: Data Table on US - Market size and forecast 2024-2029 ($ million)
• Exhibits113: Chart on US - Year-over-year growth 2024-2029 (%)
• Exhibits114: Data Table on US - Year-over-year growth 2024-2029 (%)
• Exhibits115: Chart on Canada - Market size and forecast 2024-2029 ($ million)
• Exhibits116: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
• Exhibits117: Chart on Canada - Year-over-year growth 2024-2029 (%)
• Exhibits118: Data Table on Canada - Year-over-year growth 2024-2029 (%)
• Exhibits119: Chart on China - Market size and forecast 2024-2029 ($ million)
• Exhibits120: Data Table on China - Market size and forecast 2024-2029 ($ million)
• Exhibits121: Chart on China - Year-over-year growth 2024-2029 (%)
• Exhibits122: Data Table on China - Year-over-year growth 2024-2029 (%)
• Exhibits123: Chart on Germany - Market size and forecast 2024-2029 ($ million)
• Exhibits124: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
• Exhibits125: Chart on Germany - Year-over-year growth 2024-2029 (%)
• Exhibits126: Data Table on Germany - Year-over-year growth 2024-2029 (%)
• Exhibits127: Chart on UK - Market size and forecast 2024-2029 ($ million)
• Exhibits128: Data Table on UK - Market size and forecast 2024-2029 ($ million)
• Exhibits129: Chart on UK - Year-over-year growth 2024-2029 (%)
• Exhibits130: Data Table on UK - Year-over-year growth 2024-2029 (%)
• Exhibits131: Chart on Mexico - Market size and forecast 2024-2029 ($ million)
• Exhibits132: Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
• Exhibits133: Chart on Mexico - Year-over-year growth 2024-2029 (%)
• Exhibits134: Data Table on Mexico - Year-over-year growth 2024-2029 (%)
• Exhibits135: Chart on France - Market size and forecast 2024-2029 ($ million)
• Exhibits136: Data Table on France - Market size and forecast 2024-2029 ($ million)
• Exhibits137: Chart on France - Year-over-year growth 2024-2029 (%)
• Exhibits138: Data Table on France - Year-over-year growth 2024-2029 (%)
• Exhibits139: Chart on Japan - Market size and forecast 2024-2029 ($ million)
• Exhibits140: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
• Exhibits141: Chart on Japan - Year-over-year growth 2024-2029 (%)
• Exhibits142: Data Table on Japan - Year-over-year growth 2024-2029 (%)
• Exhibits143: Chart on India - Market size and forecast 2024-2029 ($ million)
• Exhibits144: Data Table on India - Market size and forecast 2024-2029 ($ million)
• Exhibits145: Chart on India - Year-over-year growth 2024-2029 (%)
• Exhibits146: Data Table on India - Year-over-year growth 2024-2029 (%)
• Exhibits147: Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
• Exhibits148: Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
• Exhibits149: Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
• Exhibits150: Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
• Exhibits151: Market opportunity By Geographical Landscape ($ million)
• Exhibits152: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits153: Impact of drivers and challenges in 2024 and 2029
• Exhibits154: Overview on criticality of inputs and factors of differentiation
• Exhibits155: Overview on factors of disruption
• Exhibits156: Impact of key risks on business
• Exhibits157: Companies covered
• Exhibits158: Company ranking index
• Exhibits159: Matrix on companies position and classification
• Exhibits160: AiCure - Overview
• Exhibits161: AiCure - Product / Service
• Exhibits162: AiCure - Key offerings
• Exhibits163: SWOT
• Exhibits164: Atomwise Inc. - Overview
• Exhibits165: Atomwise Inc. - Product / Service
• Exhibits166: Atomwise Inc. - Key offerings
• Exhibits167: SWOT
• Exhibits168: BenevolentAI - Overview
• Exhibits169: BenevolentAI - Product / Service
• Exhibits170: BenevolentAI - Key offerings
• Exhibits171: SWOT
• Exhibits172: Boehringer Ingelheim International GmbH - Overview
• Exhibits173: Boehringer Ingelheim International GmbH - Product / Service
• Exhibits174: Boehringer Ingelheim International GmbH - Key news
• Exhibits175: Boehringer Ingelheim International GmbH - Key offerings
• Exhibits176: SWOT
• Exhibits177: Google LLC - Overview
• Exhibits178: Google LLC - Product / Service
• Exhibits179: Google LLC - Key offerings
• Exhibits180: SWOT
• Exhibits181: Insilico Medicine - Overview
• Exhibits182: Insilico Medicine - Product / Service
• Exhibits183: Insilico Medicine - Key offerings
• Exhibits184: SWOT
• Exhibits185: International Business Machines Corp. - Overview
• Exhibits186: International Business Machines Corp. - Business segments
• Exhibits187: International Business Machines Corp. - Key news
• Exhibits188: International Business Machines Corp. - Key offerings
• Exhibits189: International Business Machines Corp. - Segment focus
• Exhibits190: SWOT
• Exhibits191: Microsoft Corp. - Overview
• Exhibits192: Microsoft Corp. - Business segments
• Exhibits193: Microsoft Corp. - Key news
• Exhibits194: Microsoft Corp. - Key offerings
• Exhibits195: Microsoft Corp. - Segment focus
• Exhibits196: SWOT
• Exhibits197: NVIDIA Corp. - Overview
• Exhibits198: NVIDIA Corp. - Business segments
• Exhibits199: NVIDIA Corp. - Key news
• Exhibits200: NVIDIA Corp. - Key offerings
• Exhibits201: NVIDIA Corp. - Segment focus
• Exhibits202: SWOT
• Exhibits203: Owkin Inc. - Overview
• Exhibits204: Owkin Inc. - Product / Service
• Exhibits205: Owkin Inc. - Key offerings
• Exhibits206: SWOT
• Exhibits207: PathAI Inc. - Overview
• Exhibits208: PathAI Inc. - Product / Service
• Exhibits209: PathAI Inc. - Key offerings
• Exhibits210: SWOT
• Exhibits211: Recursion Pharmaceuticals Inc. - Overview
• Exhibits212: Recursion Pharmaceuticals Inc. - Product / Service
• Exhibits213: Recursion Pharmaceuticals Inc. - Key offerings
• Exhibits214: SWOT
• Exhibits215: Sanofi SA - Overview
• Exhibits216: Sanofi SA - Business segments
• Exhibits217: Sanofi SA - Key news
• Exhibits218: Sanofi SA - Key offerings
• Exhibits219: Sanofi SA - Segment focus
• Exhibits220: SWOT
• Exhibits221: Schrodinger Inc. - Overview
• Exhibits222: Schrodinger Inc. - Business segments
• Exhibits223: Schrodinger Inc. - Key offerings
• Exhibits224: Schrodinger Inc. - Segment focus
• Exhibits225: SWOT
• Exhibits226: SOPHiA GENETICS - Overview
• Exhibits227: SOPHiA GENETICS - Product / Service
• Exhibits228: SOPHiA GENETICS - Key offerings
• Exhibits229: SWOT
• Exhibits230: Inclusions checklist
• Exhibits231: Exclusions checklist
• Exhibits232: Currency conversion rates for US$
• Exhibits233: Research methodology
• Exhibits234: Information sources
• Exhibits235: Data validation
• Exhibits236: Validation techniques employed for market sizing
• Exhibits237: Data synthesis
• Exhibits238: 360 degree market analysis
• Exhibits239: List of abbreviations

The generative AI in life sciences market is forecasted to grow by USD 1,055.8 mn during 2024-2029, accelerating at a CAGR of 20.3% during the forecast period. The report on the generative AI in life sciences market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by imperative to enhance research and development efficiency, proliferation of high volume, multimodal biological data, and advancements in foundational AI and computing infrastructure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's generative AI in life sciences market is segmented as below:

By Application

• Drug discovery
• Personalized medicine
• Clinical trials

By Technology

• Novel molecule generation
• Protein sequence design
• Synthetic gene design

By Deployment

• Cloud-based
• On-premises
• Hybrid

By Geographical Landscape

• North America
• Europe
• APAC
• Middle East and Africa
• South America

This study identifies the emergence of integrated, closed-loop discovery platforms as one of the prime reasons driving the generative AI in life sciences market growth during the next few years. Also, development of large foundational models for biology and expansion beyond discovery into clinical and regulatory applications will lead to sizable demand in the market.

The report on the generative AI in life sciences market covers the following areas:

• Generative AI In Life Sciences Market sizing
• Generative AI In Life Sciences Market forecast
• Generative AI In Life Sciences Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading generative AI in life sciences market vendors that include AiCure, Atomwise Inc., BenevolentAI, Boehringer Ingelheim International GmbH, Clarivate PLC, Evogene Ltd., Fujitsu Ltd., Google LLC, Insilico Medicine, International Business Machines Corp., Microsoft Corp., NVIDIA Corp., Owkin Inc., PathAI Inc., Recursion Pharmaceuticals Inc., Sanofi SA, Schrodinger Inc., SOPHiA GENETICS, and Tencent Holdings Ltd.. Also, the generative AI in life sciences market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Application
  • Executive Summary - Chart on Market Segmentation by Technology
  • Executive Summary - Chart on Market Segmentation by Deployment
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value chain analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2024
• 4.4 Market outlook: Forecast for 2024-2029
  • Chart on Global - Market size and forecast 2024-2029 ($ million)
  • Data Table on Global - Market size and forecast 2024-2029 ($ million)
  • Chart on Global Market: Year-over-year growth 2024-2029 (%)
  • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Five Forces Analysis

• 5.1 Five forces summary
  • Five forces analysis - Comparison between 2024 and 2029
• 5.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2024 and 2029
• 5.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
• 5.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2024 and 2029
• 5.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2024 and 2029
• 5.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2024 and 2029
• 5.7 Market condition
  • Chart on Market condition - Five forces 2024 and 2029

6 Market Segmentation by Application

• 6.1 Market segments
  • Chart on Application - Market share 2024-2029 (%)
  • Data Table on Application - Market share 2024-2029 (%)
• 6.2 Comparison by Application
  • Chart on Comparison by Application
  • Data Table on Comparison by Application
• 6.3 Drug discovery - Market size and forecast 2024-2029
  • Chart on Drug discovery - Market size and forecast 2024-2029 ($ million)
  • Data Table on Drug discovery - Market size and forecast 2024-2029 ($ million)
  • Chart on Drug discovery - Year-over-year growth 2024-2029 (%)
  • Data Table on Drug discovery - Year-over-year growth 2024-2029 (%)
• 6.4 Personalized medicine - Market size and forecast 2024-2029
  • Chart on Personalized medicine - Market size and forecast 2024-2029 ($ million)
  • Data Table on Personalized medicine - Market size and forecast 2024-2029 ($ million)
  • Chart on Personalized medicine - Year-over-year growth 2024-2029 (%)
  • Data Table on Personalized medicine - Year-over-year growth 2024-2029 (%)
• 6.5 Clinical trials - Market size and forecast 2024-2029
  • Chart on Clinical trials - Market size and forecast 2024-2029 ($ million)
  • Data Table on Clinical trials - Market size and forecast 2024-2029 ($ million)
  • Chart on Clinical trials - Year-over-year growth 2024-2029 (%)
  • Data Table on Clinical trials - Year-over-year growth 2024-2029 (%)
• 6.6 Market opportunity by Application
  • Market opportunity by Application ($ million)
  • Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Technology

• 7.1 Market segments
  • Chart on Technology - Market share 2024-2029 (%)
  • Data Table on Technology - Market share 2024-2029 (%)
• 7.2 Comparison by Technology
  • Chart on Comparison by Technology
  • Data Table on Comparison by Technology
• 7.3 Novel molecule generation - Market size and forecast 2024-2029
  • Chart on Novel molecule generation - Market size and forecast 2024-2029 ($ million)
  • Data Table on Novel molecule generation - Market size and forecast 2024-2029 ($ million)
  • Chart on Novel molecule generation - Year-over-year growth 2024-2029 (%)
  • Data Table on Novel molecule generation - Year-over-year growth 2024-2029 (%)
• 7.4 Protein sequence design - Market size and forecast 2024-2029
  • Chart on Protein sequence design - Market size and forecast 2024-2029 ($ million)
  • Data Table on Protein sequence design - Market size and forecast 2024-2029 ($ million)
  • Chart on Protein sequence design - Year-over-year growth 2024-2029 (%)
  • Data Table on Protein sequence design - Year-over-year growth 2024-2029 (%)
• 7.5 Synthetic gene design - Market size and forecast 2024-2029
  • Chart on Synthetic gene design - Market size and forecast 2024-2029 ($ million)
  • Data Table on Synthetic gene design - Market size and forecast 2024-2029 ($ million)
  • Chart on Synthetic gene design - Year-over-year growth 2024-2029 (%)
  • Data Table on Synthetic gene design - Year-over-year growth 2024-2029 (%)
• 7.6 Market opportunity by Technology
  • Market opportunity by Technology ($ million)
  • Data Table on Market opportunity by Technology ($ million)

8 Market Segmentation by Deployment

• 8.1 Market segments
  • Chart on Deployment - Market share 2024-2029 (%)
  • Data Table on Deployment - Market share 2024-2029 (%)
• 8.2 Comparison by Deployment
  • Chart on Comparison by Deployment
  • Data Table on Comparison by Deployment
• 8.3 Cloud-based - Market size and forecast 2024-2029
  • Chart on Cloud-based - Market size and forecast 2024-2029 ($ million)
  • Data Table on Cloud-based - Market size and forecast 2024-2029 ($ million)
  • Chart on Cloud-based - Year-over-year growth 2024-2029 (%)
  • Data Table on Cloud-based - Year-over-year growth 2024-2029 (%)
• 8.4 On-premises - Market size and forecast 2024-2029
  • Chart on On-premises - Market size and forecast 2024-2029 ($ million)
  • Data Table on On-premises - Market size and forecast 2024-2029 ($ million)
  • Chart on On-premises - Year-over-year growth 2024-2029 (%)
  • Data Table on On-premises - Year-over-year growth 2024-2029 (%)
• 8.5 Hybrid - Market size and forecast 2024-2029
  • Chart on Hybrid - Market size and forecast 2024-2029 ($ million)
  • Data Table on Hybrid - Market size and forecast 2024-2029 ($ million)
  • Chart on Hybrid - Year-over-year growth 2024-2029 (%)
  • Data Table on Hybrid - Year-over-year growth 2024-2029 (%)
• 8.6 Market opportunity by Deployment
  • Market opportunity by Deployment ($ million)
  • Data Table on Market opportunity by Deployment ($ million)

9 Customer Landscape

• 9.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

10 Geographic Landscape

• 10.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2024-2029 (%)
  • Data Table on Market share By Geographical Landscape 2024-2029 (%)
• 10.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 10.3 North America - Market size and forecast 2024-2029
  • Chart on North America - Market size and forecast 2024-2029 ($ million)
  • Data Table on North America - Market size and forecast 2024-2029 ($ million)
  • Chart on North America - Year-over-year growth 2024-2029 (%)
  • Data Table on North America - Year-over-year growth 2024-2029 (%)
• 10.4 Europe - Market size and forecast 2024-2029
  • Chart on Europe - Market size and forecast 2024-2029 ($ million)
  • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
  • Chart on Europe - Year-over-year growth 2024-2029 (%)
  • Data Table on Europe - Year-over-year growth 2024-2029 (%)
• 10.5 APAC - Market size and forecast 2024-2029
  • Chart on APAC - Market size and forecast 2024-2029 ($ million)
  • Data Table on APAC - Market size and forecast 2024-2029 ($ million)
  • Chart on APAC - Year-over-year growth 2024-2029 (%)
  • Data Table on APAC - Year-over-year growth 2024-2029 (%)
• 10.6 Middle East and Africa - Market size and forecast 2024-2029
  • Chart on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
  • Data Table on Middle East and Africa - Market size and forecast 2024-2029 ($ million)
  • Chart on Middle East and Africa - Year-over-year growth 2024-2029 (%)
  • Data Table on Middle East and Africa - Year-over-year growth 2024-2029 (%)
• 10.7 South America - Market size and forecast 2024-2029
  • Chart on South America - Market size and forecast 2024-2029 ($ million)
  • Data Table on South America - Market size and forecast 2024-2029 ($ million)
  • Chart on South America - Year-over-year growth 2024-2029 (%)
  • Data Table on South America - Year-over-year growth 2024-2029 (%)
• 10.8 US - Market size and forecast 2024-2029
  • Chart on US - Market size and forecast 2024-2029 ($ million)
  • Data Table on US - Market size and forecast 2024-2029 ($ million)
  • Chart on US - Year-over-year growth 2024-2029 (%)
  • Data Table on US - Year-over-year growth 2024-2029 (%)
• 10.9 Canada - Market size and forecast 2024-2029
  • Chart on Canada - Market size and forecast 2024-2029 ($ million)
  • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
  • Chart on Canada - Year-over-year growth 2024-2029 (%)
  • Data Table on Canada - Year-over-year growth 2024-2029 (%)
• 10.10 China - Market size and forecast 2024-2029
  • Chart on China - Market size and forecast 2024-2029 ($ million)
  • Data Table on China - Market size and forecast 2024-2029 ($ million)
  • Chart on China - Year-over-year growth 2024-2029 (%)
  • Data Table on China - Year-over-year growth 2024-2029 (%)
• 10.11 Germany - Market size and forecast 2024-2029
  • Chart on Germany - Market size and forecast 2024-2029 ($ million)
  • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
  • Chart on Germany - Year-over-year growth 2024-2029 (%)
  • Data Table on Germany - Year-over-year growth 2024-2029 (%)
• 10.12 UK - Market size and forecast 2024-2029
  • Chart on UK - Market size and forecast 2024-2029 ($ million)
  • Data Table on UK - Market size and forecast 2024-2029 ($ million)
  • Chart on UK - Year-over-year growth 2024-2029 (%)
  • Data Table on UK - Year-over-year growth 2024-2029 (%)
• 10.13 Mexico - Market size and forecast 2024-2029
  • Chart on Mexico - Market size and forecast 2024-2029 ($ million)
  • Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
  • Chart on Mexico - Year-over-year growth 2024-2029 (%)
  • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
• 10.14 France - Market size and forecast 2024-2029
  • Chart on France - Market size and forecast 2024-2029 ($ million)
  • Data Table on France - Market size and forecast 2024-2029 ($ million)
  • Chart on France - Year-over-year growth 2024-2029 (%)
  • Data Table on France - Year-over-year growth 2024-2029 (%)
• 10.15 Japan - Market size and forecast 2024-2029
  • Chart on Japan - Market size and forecast 2024-2029 ($ million)
  • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
  • Chart on Japan - Year-over-year growth 2024-2029 (%)
  • Data Table on Japan - Year-over-year growth 2024-2029 (%)
• 10.16 India - Market size and forecast 2024-2029
  • Chart on India - Market size and forecast 2024-2029 ($ million)
  • Data Table on India - Market size and forecast 2024-2029 ($ million)
  • Chart on India - Year-over-year growth 2024-2029 (%)
  • Data Table on India - Year-over-year growth 2024-2029 (%)
• 10.17 The Netherlands - Market size and forecast 2024-2029
  • Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
  • Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
  • Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
  • Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
• 10.18 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

11 Drivers, Challenges, and Opportunity/Restraints

• 11.1 Market drivers
• 11.2 Market challenges
• 11.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2024 and 2029
• 11.4 Market opportunities/restraints

12 Competitive Landscape

• 12.1 Overview
• 12.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 12.3 Landscape disruption
  • Overview on factors of disruption
• 12.4 Industry risks
  • Impact of key risks on business

13 Competitive Analysis

• 13.1 Companies profiled
  • Companies covered
• 13.2 Company ranking index
  • Company ranking index
• 13.3 Market positioning of companies
  • Matrix on companies position and classification
• 13.4 AiCure
  • AiCure - Overview
  • AiCure - Product / Service
  • AiCure - Key offerings
  • SWOT
• 13.5 Atomwise Inc.
  • Atomwise Inc. - Overview
  • Atomwise Inc. - Product / Service
  • Atomwise Inc. - Key offerings
  • SWOT
• 13.6 BenevolentAI
  • BenevolentAI - Overview
  • BenevolentAI - Product / Service
  • BenevolentAI - Key offerings
  • SWOT
• 13.7 Boehringer Ingelheim International GmbH
  • Boehringer Ingelheim International GmbH - Overview
  • Boehringer Ingelheim International GmbH - Product / Service
  • Boehringer Ingelheim International GmbH - Key news
  • Boehringer Ingelheim International GmbH - Key offerings
  • SWOT
• 13.8 Google LLC
  • Google LLC - Overview
  • Google LLC - Product / Service
  • Google LLC - Key offerings
  • SWOT
• 13.9 Insilico Medicine
  • Insilico Medicine - Overview
  • Insilico Medicine - Product / Service
  • Insilico Medicine - Key offerings
  • SWOT
• 13.10 International Business Machines Corp.
  • International Business Machines Corp. - Overview
  • International Business Machines Corp. - Business segments
  • International Business Machines Corp. - Key news
  • International Business Machines Corp. - Key offerings
  • International Business Machines Corp. - Segment focus
  • SWOT
• 13.11 Microsoft Corp.
  • Microsoft Corp. - Overview
  • Microsoft Corp. - Business segments
  • Microsoft Corp. - Key news
  • Microsoft Corp. - Key offerings
  • Microsoft Corp. - Segment focus
  • SWOT
• 13.12 NVIDIA Corp.
  • NVIDIA Corp. - Overview
  • NVIDIA Corp. - Business segments
  • NVIDIA Corp. - Key news
  • NVIDIA Corp. - Key offerings
  • NVIDIA Corp. - Segment focus
  • SWOT
• 13.13 Owkin Inc.
  • Owkin Inc. - Overview
  • Owkin Inc. - Product / Service
  • Owkin Inc. - Key offerings
  • SWOT
• 13.14 PathAI Inc.
  • PathAI Inc. - Overview
  • PathAI Inc. - Product / Service
  • PathAI Inc. - Key offerings
  • SWOT
• 13.15 Recursion Pharmaceuticals Inc.
  • Recursion Pharmaceuticals Inc. - Overview
  • Recursion Pharmaceuticals Inc. - Product / Service
  • Recursion Pharmaceuticals Inc. - Key offerings
  • SWOT
• 13.16 Sanofi SA
  • Sanofi SA - Overview
  • Sanofi SA - Business segments
  • Sanofi SA - Key news
  • Sanofi SA - Key offerings
  • Sanofi SA - Segment focus
  • SWOT
• 13.17 Schrodinger Inc.
  • Schrodinger Inc. - Overview
  • Schrodinger Inc. - Business segments
  • Schrodinger Inc. - Key offerings
  • Schrodinger Inc. - Segment focus
  • SWOT
• 13.18 SOPHiA GENETICS
  • SOPHiA GENETICS - Overview
  • SOPHiA GENETICS - Product / Service
  • SOPHiA GENETICS - Key offerings
  • SWOT

14 Appendix

• 14.1 Scope of the report
• 14.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 14.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 14.4 Research methodology
  • Research methodology
• 14.5 Data procurement
  • Information sources
• 14.6 Data validation
  • Data validation
• 14.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 14.8 Data synthesis
  • Data synthesis
• 14.9 360 degree market analysis
  • 360 degree market analysis
• 14.10 List of abbreviations
  • List of abbreviations